ONC.L
Oncimmune Holdings plc develops and commercializes technologies that enable cancer diagnosis in the United Kingdom, North America, Europe, and internationally. It offers EarlyCDT-Lung, a immunodiagnostic test for detecting and identifying lung cancer. The company also develops SeroTag, a platform that is used to discover and validate biomarkers for stratifying patients in multiple cancer indications, infectious diseases, and with various autoimmune diseases; and NavigAID, a disease-specific characterization panel. Oncimmune Holdings plc was incorporated in 2015 and is based in Nottingham, the United Kingdom.
Industry
Biotechnology
IPO Date
2016-05-18
Stock Exchange
LSE
Ticker
ONC.L
According to Oncimmune Holdings plc’s latest financial reports and current stock price. The company's current PE Ratio is -0.23. This represents a change of -84.41% compared to the average of -1.48 of the last 4 quarters.
The mean historical PE Ratio of Oncimmune Holdings plc over the last ten years is -11.48. The current -0.23 PE Ratio has changed 100.34% with respect to the historical average. Over the past ten years (40 quarters), ONC.L's PE Ratio was at its highest in in the August 2023 quarter at 0.53. The PE Ratio was at its lowest in in the March 2014 quarter at -47.88.
Average
-11.48
Median
-7.72
Minimum
-33.59
Maximum
4.10
Discovering the peaks and valleys of Oncimmune Holdings plc PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 245.18%
Maximum Annual PE Ratio = 4.10
Minimum Annual Increase = -187.50%
Minimum Annual PE Ratio = -33.59
| Year | PE Ratio | Change |
|---|---|---|
| 2024 | -3.59 | -187.50% |
| 2023 | 4.10 | -161.95% |
| 2022 | -6.62 | -76.92% |
| 2021 | -28.67 | 245.18% |
| 2020 | -8.31 | 16.45% |
| 2019 | -7.13 | -35.96% |
| 2018 | -11.14 | -22.24% |
| 2017 | -14.32 | 158.33% |
| 2016 | -5.54 | -83.49% |
| 2015 | -33.59 | -29.86% |
The current PE Ratio of Oncimmune Holdings plc (ONC.L) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-2.03
5-year avg
-8.62
10-year avg
-11.48
Oncimmune Holdings plc’s PE Ratio is less than Oxford Cannabinoid Technologies Holdings Plc (-0.19), greater than LungLife AI, Inc. (-0.26), less than Ovoca Bio plc (-0.17), less than LungLife AI, Inc. (0), less than Kanabo Group Plc (-0.15), less than DeepVerge plc (-0.11), less than ReNeuron Group plc (-0.01), greater than Hellenic Dynamics Plc (-0.27), less than Totally plc (100.00), greater than Destiny Pharma plc (-0.48),
| Company | PE Ratio | Market cap |
|---|---|---|
| -0.19 | N/A | |
| -0.26 | N/A | |
| -0.17 | N/A | |
| 0 | N/A | |
| -0.15 | N/A | |
| -0.11 | N/A | |
| -0.01 | N/A | |
| -0.27 | N/A | |
| 100.00 | N/A | |
| -0.48 | N/A |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Oncimmune Holdings plc using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Oncimmune Holdings plc or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Oncimmune Holdings plc's PE Ratio?
How is the PE Ratio calculated for Oncimmune Holdings plc (ONC.L)?
What is the highest PE Ratio for Oncimmune Holdings plc (ONC.L)?
What is the 3-year average PE Ratio for Oncimmune Holdings plc (ONC.L)?
What is the 5-year average PE Ratio for Oncimmune Holdings plc (ONC.L)?
How does the current PE Ratio for Oncimmune Holdings plc (ONC.L) compare to its historical average?